ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

LeMaistre Succeeds Lee Clark As Head Of U. Texas Center

March 10, 1978

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

In Brief: Less Hazardous Cigarette Only Hope To Reduce Smoking Health Problems, Carter Advisor Says

November 25, 1977